Literature DB >> 3922771

Correlation of disease activity in systemic vasculitis with serum C-reactive protein measurement. A prospective study of thirty-eight patients.

C R Hind, C G Winearls, M B Pepys.   

Abstract

In a prospective study over 2 years, serum C-reactive protein (CRP) concentration and erythrocyte sedimentation rate were measured serially in thirty-eight patients with various types of necrotizing systemic vasculitis. The CRP concentration was always elevated in patients with active vasculitis and fell rapidly in association with clinical remission induced by immunosuppression. During periods of complete remission, in the absence of any intercurrent condition, the value remained within the normal range. In contrast the sedimentation rate responded more slowly to changes in disease activity and did not necessarily reflect the level of inflammation at a particular time. These results, together with the commercial availability of rapid and precise assays for CRP, indicate that serial measurement of the serum CRP fills the urgent need for an objective index of the activity of the systemic vasculitides and their response to therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922771     DOI: 10.1111/j.1365-2362.1985.tb00150.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Release of interleukin-1 by peripheral blood mononuclear cells in patients with tuberculosis and active inflammation.

Authors:  S W Chensue; M P Davey; D G Remick; S L Kunkel
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  C-reactive protein and the acute phase reaction in geriatric patients.

Authors:  Thomas Bertsch; Jakob Triebel; Cornelius Bollheimer; Michael Christ; Cornel Sieber; Klaus Fassbender; Hans Jürgen Heppner
Journal:  Z Gerontol Geriatr       Date:  2015-09-03       Impact factor: 1.281

3.  Serial study of C-reactive protein during fungal esophagitis and enterocolitis.

Authors:  I Kostiala; A A Kostiala; E Elonen
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.